LH News and Press, Laboratory Corporation of America Holdings From 10/27/22

Laboratory Corporation of America Holdings (LH) Q3 2022 Earnings Conference Call October 27, 2022, 09:00 ET Company Participants Chas Cook - VP, IR Adam Schechter - President, CEO & Chairman Glenn Eisenberg - CFO & EVP Conference Call Participants ...

Labcorp ( NYSE: LH ) stock is trading lower after Q3 revenue came below estimates and the company cut its FY22 outlook. The Burlington, N.C.-based company's Adjusted EPS fell ~31.4% Y/Y to $4.68, and came in line with analysts' expectations. Total revenues fell -...

Laboratory Corporation of America press release ( NYSE: LH ): Q3 Non-GAAP EPS of $4.68 in-line. Revenue of $3.6B (-12.2% Y/Y) misses by $190M . For FY2022, the company expects total revenue  to decline -7.5% to -6% Y/Y down from prior outlook of -6% to -2% and...

Company Updates Full-Year Guidance Revenue: Q3 of $3.6 billion versus $4.1 billion last year Diluted EPS: Q3 of $3.90 versus $6.05 last year Adjusted EPS: Q3 of $4.68 versus $6.82 last year Free Cash Flow: Q3 of $270 million versus $650 million last year Progre...

Laboratory Corporation of America ( NYSE: LH ) is scheduled to announce Q3 earnings results on Thursday, October 27th, before market open. The consensus EPS Estimate is $4.68 (-31.4% Y/Y) and the consensus Revenue Estimate is $3.79B (-7.6% Y/Y). Over the last 2 years, ...

Summary Guardant Health derives most of its revenue from FDA-approved liquid-biopsy services as opposed to CLIA-waived laboratory-developed tests "LDT". As the FDA prepares to extend its regulatory arm over LDT, it might be a good idea to shift your investment exposure to companie...

Labcorp (NYSE: LH), a leading global life sciences company, today announced that Kirsten Kliphouse, president of Americas, Google Cloud, has joined its Board of Directors as an independent member. This press release features multimedia. View the full release here: https://www.busi...

Summary As EXAS continues shifting its business models from "growth at all costs" to "profitable growth" in response to rising capital costs, its sales will expand at a slower pace. Despite the expected normalization in growth, in my view, the market will likely reward improved ma...

Labcorp (NYSE: LH), a leading global life sciences company, today announced the completion of transactions that establish a long-term laboratory relationship with Ascension, one of the leading non-profit and Catholic health systems in the United States. “Today’s announ...

Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the third quarter of 2022 before the market opens on Thursday, Oct. 27, 2022. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results...